Allurion Technologies, Inc. Warrants, each whole warrant exerci — Quarterly Financial Statistics (NYSE:ALUR-WT) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 11.44 M13.3 M9.5 M7.6 M6.5 M 36.9 M Cash from investing activities 72 K0104 K435 K72 K — Cash from financing activities 19.59 M-53 K14.5 M-71 K-55 K 14.32 M Free cash flow 11.37 M13.3 M9.5 M7.6 M6.5 M 36.9 M

ニュース

Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year?

Allurion Technologiesがワラント条件を修正し、誘引オファーで300万ドルを調達

What's Going On With Allurion Stock On Wednesday? - Allurion Technologies (NYSE:ALUR)

FDA承認を受けてAllurion Technologies株の格付けが引き上げられる

Allurion Technologies stock rating upgraded on FDA approval

Allurion株が米国FDA承認を受けて40%急騰

FDA approves Allurion gastric balloon for obesity treatment

Allurion stock surges 40% on U.S. FDA approval

Tracking Saudi Sovereign Wealth Fund’s 13F Portfolio – Q3 2025 Update

アルリオン・テクノロジーズの取締役、約4.9千ドル相当の株式を売却

Allurion Technologies (ALUR) director sells $4.9k in shares

Allurion reports 23% weight loss combining balloon with low-dose GLP-1